Pharma Research Services (CROs/SMOs)
Contract research organisations and site management organisations deliver outsourced trial execution and patient recruitment.
Capturing Value in Clinical Research and Site Management
Clinical research organisations (CROs) and site management organisations (SMOs) are central to the delivery of modern drug development. Demand for outsourced services continues to grow as sponsors seek efficiency, access to specialist expertise, and global reach.
President Donald Trump’s threats to tariff pharmaceutical companies have had a marked impact, with pharmaceutical companies being told to conduct more of their clinical research on US patients.
We support investors and management teams in evaluating opportunities across the clinical services landscape. Our work includes commercial due diligence, transaction support, and growth strategy development. We assess market dynamics by geography and therapeutic area, benchmark financial performance, and analyse contract pipelines to provide a realistic view of growth prospects.
Our pharma services (CROs/SMOs) leads
Our teams combine scientific and operational knowledge with transaction experience. We review competitive positioning, pricing structures, regulatory expectations, and digital adoption to understand where genuine differentiation exists. This ensures investment cases are built on credible assumptions and highlight where risks may outweigh opportunities.
Beyond transaction assessments, we advise on strategic growth levers such as service line expansion, geographic scaling, and partnership strategies with pharma and biotech sponsors. By combining rigorous analysis with practical insight, we help CROs and SMOs position for sustainable growth in an increasingly sophisticated and global market.
News & Insights
Our pharma Insights
News & Insights
Healthcare news, data and analysis
Via Investors in Healthcare
Cheplapharm, a family-run pharmaceutical company headquartered in Germany, specialising in the development, marketing, and distribution of branded pharmaceutical products, is aligning its management board for the company’s next phase of growth. As part of […]
Germany: Cheplapharm aligns management board for next phase of growth
18 May 2026
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
,
Cheplapharm
Water Street Healthcare Partners has held the first and final close of its sixth private equity fund at US$1.9bn. Fund VI was oversubscribed and closed at its hard cap. With […]
US: Water Street Healthcare Partners holds first and final close of Fund VI at US$1.9bn
18 May 2026
Buy Out
,
Diagnostics
,
Healthcare
,
Life Sciences
,
Medtech – Diagnostics
Dirk Scholz has taken up his new role as CFO of the Sanner Group, a Germany-based global healthcare packaging and medical device CDMO. He succeeds Henrik Bøggild, who left Sanner after […]
Germany: Sanner Group appoints Dirk Scholz as new CFO
15 May 2026
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
,
Dirk Scholz
CordenPharma, a Swiss-based full-service CDMO of APIs, lipid excipients, drug products and packaging, has appointed Marc Augustin as CFO. Augustin joins from PolyPeptide where he spent over two years as […]
Switzerland: CordenPharma appoints Marc Augustin as CFO
13 May 2026
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
,
CordenPharma
Columna Capital has acquired a majority stake in Evidenze Group, a Spain‑based full‑service CRO, from Buenavista Equity Partners. The UK‑based pan‑European lower mid‑market investor is partnering with Evidenze co‑founders Pedro […]
Spain: Columna Capital acquires majority stake in Evidenze Group from Buenavista Equity Partners
5 May 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Panthera Biopartners (Panthera), the LDC-backed UK based clinical trial Site Management Organisation (SMO), has announced the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), a Hungary-based independent clinical research site network. […]
Hungary: LDC-backed Panthera Biopartners takes first major step in European expansion strategy
27 April 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners acquired a majority stake in Tjoapack […]
Netherlands: Alcami to acquire contract packaging organisation Tjoapack
24 April 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands our Life Sciences clinical research […]
Germany: Innodiab expands Certania’s Life Sciences capabilities in diabetes and obesity
23 April 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
German mittelstand investor, Rantum Capital, through its Private Equity Fund II, has acquired Tontarra Medizintechnik, a leading German developer and manufacturer of high-precision, premium surgical instruments and endoscopy products for […]
Germany: Rantum Capital invests in next phase of Tontarra’s development
2 April 2026
Buy Out
,
Life Sciences
,
M&A
,
Medtech – Hospital Equipment
,
News
Prescient Healthcare Group, a UK-based product strategy consultancy to the global biopharmaceutical industry, has acquired London-based pricing and market access consultancy Dolon, strengthening its ability to support global biopharma companies navigating […]
UK: Prescient strengthens pricing and market access capabilities with Dolon
31 March 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
MTIP, a Switzerland-based specialist growth and buyout investor focused on European healthcare technology, has made a strategic investment in Verifarma, a Spain-headquartered provider of integrated serialisation, traceability, and regulatory compliance […]
Spain: MTIP makes strategic investment in Verifarma
30 March 2026
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
,
Venture
ProductLife Group (PLG), a European provider of outsourced development, regulatory and compliance services to the global life sciences industry, has appointed Dr James Burt as CEO. The appointment marks start […]
France: PLG appoints James Burt as CEO
25 March 2026
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
,
France
An investor group led by Apollo is acquiring a 37% minority stake in Syntegon from CVC, marking the starting point for the firm’s next growth phase. Syntegon is a Germany-based […]
Germany: Apollo acquires minority stake in Syntegon from CVC
23 March 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Germany-based CDMO, 1Q Health Group, has acquired EHF Production, a contract manufacturer based in the Netherlands. EHF Production has been developing and manufacturing supplements for over 25 years and is an […]
The Netherlands: 1Q Health expands CDMO capabilities with acquisition of EHF Production
16 March 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
UK-based life sciences marketing agency, ramarketing, has acquired US-based ISR Market Research, a specialist provider of primary research for the pharmaceutical outsourcing sector, including CDMOs and CROs. The move brings […]
UK: ramarketing acquires US market research firm ISR
10 March 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Switzerland-listed Lonza has agreed to sell its Capsules & Health Ingredients (CHI) business to UK-based Lone Star Funds for an enterprise value of CHF2.3bn (US$3bn. Headquartered in Basel, CHI operates […]
Switzerland: Lonza completing transformation to pure-play CDMO with divestment of Capsules & Health Ingredients
9 March 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Public Equity
Authors Dr Lakshiv Dhingra, Dr Seren Marsh, Abhishek Patel and Dr Victor Chua of Mansfield Advisors consider how the GLP-1 landscape will evolve over the next 10 years in light […]
GLP-1 2.0: Where the next wave of value will be created
27 February 2026
Analysis
,
Consumer Healthcare
,
Cosmetic & Aesthetics
,
Healthcare
,
Manufacturing – Generics
Biomapas, a pan-European pharma services provider based in Lithuania, has appointed Xavier Duburcq as CEO, marking the start of a new chapter as the company prepares to accelerate its next phase of growth. He succeeds David […]
Lithuania: Biomapas appoints Xavier Duburcq as CEO as it accelerates towards €200m-plus ambition
26 February 2026
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
,
Biomapas
Ampersand Capital Partners, a private equity firm specialising in growth investments in the life sciences and healthcare sectors, has acquired Purna Pharmaceuticals, an independent Belgium-based company providing development and manufacturing services […]
Belgium: Purna and MedPharm establish Trans-Atlantic pharma services partnership
17 February 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
LBO France has agreed the sale of Dutscher Group, a France-based distributor of consumables and equipment for R&D laboratories, to US healthcare and life sciences investment firm Vivo Capital – […]
France: Vivo Cap makes first buyout in Europe taking Dutscher from LBO France
5 February 2026
Buy Out
,
Life Sciences
,
M&A
,
News
,
Pharma
Evestia Clinical, an independent UK-based global specialist CRO, has acquired ICRC-Weyer, a Germany-based CRO and scientific consultancy. The acquisition strengthens Evestia Clinical’s presence in Germany and Europe and enhances its […]
Germany: Kester-backed Evestia Clinical strengthens presence in Europe with acquisition of ICRC-Weyer
28 January 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Life sciences PE Firm, SK Capital, is to sell the drug substance business of the Noramco Group and Extractas Bioscience to Six-listed Siegfried Holding, a Switzerland-based CDMO. Following the transaction […]
Switzerland: SK Capital to sell Noramco, Extractas Bioscience, and Purisys to Siegfried
28 January 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Thematic investor Gilde Healthcare has expanded its Surgical Instrument Contract Manufacturing Group (the Group) with the acquisition of Germany-based medtech Rudischhauser Surgical Instruments Manufacturing, a specialist manufacturer of complex surgical […]
Germany: Rudischhauser becomes latest addition to Gilde’s Surgical Instrument Contract Manufacturing Group
26 January 2026
Buy Out
,
Life Sciences
,
M&A
,
Medtech – Medical Devices and Implants
,
News
UK-based Specac, an Ampersand Capital Partners portfolio company that designs and manufactures spectroscopy accessories and sample prep solutions, has acquired Amax Precision, a Singapore-headquartered analytical instrument precision contract manufacturer. […]
Singapore: Specac acquires Amax Precision
23 January 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
Buenavista Equity Partners, a private equity group specialising in the Spanish low/mid-market segment, and Spain-based Columbus Venture Partners, are selling their stake in Syngoi Technologies, a Spain-based CDMO specialising in synthetic […]
Spain: Artis BioSolutions acquires CDMO Syngoi Technologies
22 January 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO